Peer-influenced content. Sources you trust. No registration required. This is HCN.
Epoch Health
23 million Americans take levothyroxine daily, making it one of the nation’s most prescribed medications, with new evidence suggesting potential risks to bone health even at standard therapeutic levels.
Endocrinology, Diabetes, Metabolism December 4th 2024
The New England Journal of Medicine
Weekly semaglutide administration achieved a 13.7% weight reduction while demonstrating significant improvements in knee osteoarthritis pain, potentially offering a new therapeutic approach for this challenging patient population.
Endocrinology, Diabetes, Metabolism November 21st 2024
Cleveland Clinic Journal of Medicine
“Pulmonary arterial hypertension, a rare [form] of pulmonary hypertension, has a disproportionate impact on women,” wrote investigator Vallerie V. McLaughlin, MD, and co-authors in a published abstract for the study.
Cardiology November 11th 2024
Acne fulminans, a severe variant of inflammatory acne, can present with systemic symptoms and requires prompt, aggressive treatment. This case study outlines a successful treatment approach with oral glucocorticoids, isotretinoin, and topical antimicrobials.
Dermatology October 24th 2024
Salt-and-pepper skin pigmentation can be an early indicator of systemic sclerosis, characterized by vitiligo-like depigmentation with sparing of perifollicular areas.
Allergy & Immunology October 14th 2024
Convincing bone loss would be bone loss at more than 1 site or over more than 1 interval, or bone loss associated with elevated markers of bone turnover such as cross-linked C-telopeptide of type-1 collagen (CTx) greater than 300 pg/mL.
Endocrinology, Diabetes, Metabolism October 8th 2024